HIV-1 Coinfection Does Not Reduce Exposure to Rifampin, Isoniazid, and Pyrazinamide in South African Tuberculosis Outpatients

There are contrasting data in the literature about antituberculosis plasma drug concentrations in HIV-1-coinfected patients. We report the pharmacokinetics of rifampin, isoniazid, and pyrazinamide in a cohort of patients being treated for active tuberculosis, the majority of whom were coinfected wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Rockwood, Neesha, Meintjes, Graeme, Chirehwa, Maxwell, Wiesner, Lubbe, McIlleron, Helen, Wilkinson, Robert J., Denti, Paolo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2016
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038257/
https://www.ncbi.nlm.nih.gov/pubmed/27480859
http://dx.doi.org/10.1128/AAC.00480-16

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5038257/
https://www.ncbi.nlm.nih.gov/pubmed/27480859
http://dx.doi.org/10.1128/AAC.00480-16

Ejemplares similares